From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.92 CNY | +1.82% | +4.81% | -11.71% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.71% | 1.03B | |
+37.08% | 6.01B | |
-17.43% | 4.4B | |
-9.46% | 3.17B | |
+0.51% | 3.07B | |
-3.53% | 2.51B | |
+41.15% | 1.88B | |
-5.15% | 1.73B | |
+0.09% | 1.65B | |
-10.38% | 1.58B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.